Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1

Cerebellum

Volumn 14, Issue 6, 2015, Pages 642-649

  Toelle, Sandra P ^a   Poretti, Andrea ^a,b   Weber, Peter ^c   Seute, Tatjana ^d   Bromberg, Jacoline E C ^e   Scheer, Ianina ^a   Boltshauser, Eugen ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

Cerebellar dysmorphia; Cerebellar hypoplasia; Cerebellum; Neurofibromatosis type 1; Neuroimaging

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATAXIA; ATAXIC GAIT; BRAIN MAGNETIC RESONANCE IMAGING; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBELLAR DYSMORPHIA; CEREBELLUM DISEASE; CEREBELLUM HYPOPLASIA; CHILD; CLINICAL ARTICLE; COLLAPSE; COORDINATION DISORDER; DEPTH PERCEPTION; DIPLOPIA; FEMALE; GLIOBLASTOMA; HUMAN; HYDROCEPHALUS; LANGUAGE DISABILITY; LEARNING DISORDER; MALE; NEUROFIBROMA; NEUROFIBROMATOSIS TYPE 1; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STANDING ATAXIA; YOUNG ADULT; BRAIN; CEREBELLUM; COMPLICATION; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; FOLLOW UP; NERVOUS SYSTEM MALFORMATION; PATHOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; BRAIN; CEREBELLUM; CHILD; DEVELOPMENTAL DISABILITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM MALFORMATIONS; NEUROFIBROMATOSIS 1; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84946489235     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-015-0658-8     Document Type: Article

References (38)

1. Williams VC, Lucas J, Babcock MA, et al. Neurofibromatosis type 1 revisited. Pediatrics. 2009;123:124–33.
2. Plotkin SR, Albers AC, Babovic-Vuksanovic D, et al. Update from the 2013 international neurofibromatosis conference. Am J Med Genet A. 2014;164:2969–78.
3. Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014;13:834–43.
4. Acosta MT, Gioia GA, Silva AJ. Neurofibromatosis type 1: new insights into neurocognitive issues. Curr Neurol Neurosci Rep. 2006;6:136–43.
5. Acosta MT, Kardel PG, Walsh KS, et al. Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. Pediatr Neurol. 2011;45:241–5.
6. Lidzba K, Granstrom S, Lindenau J, Mautner VF. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1. Dev Med Child Neurol. 2012;54:892–7.
7. Soucy EA, Gao F, Gutmann DH, Dunn CM. Developmental delays in children with neurofibromatosis type 1. J Child Neurol. 2012;27:641–4.
8. Champion JA, Rose KJ, Payne JM, Burns J, North KN. Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1. Dev Med Child Neurol. 2014;56:468–74.
9. DiMario Jr FJ, Ramsby G. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol. 1998;55:500–5.
10. Payne JM, Pickering T, Porter M, et al. Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study. Am J Med Genet A. 2014;164A:661–5.
11. Albers AC, Gutmann DH. Gliomas in patients with neurofibromatosis type 1. Expert Rev Neurother. 2009;9:535–9.
12. Fisher MJ, Avery RA, Allen JC, et al. Functional outcome measures for NF1-associated optic pathway glioma clinical trials. Neurology. 2013;81:S15–24.
13. Piscitelli O, Digilio MC, Capolino R, Longo D, Di Ciommo V. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning. Dev Med Child Neurol. 2012;54:49–51.
14. Pascual-Castroviejo I, Pascual-Pascual SI, Viano J, et al. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst. 2010;26:1599–603.
15. Riccardi VM. Neurofibromatosis. Baltimore: The Johns Hopkins University Press; 1992. p. 63.
16. Poretti A, Boltshauser E, Doherty D. Cerebellar hypoplasia: differential diagnosis and diagnostic approach. Am J Med Genet C: Semin Med Genet. 2014;166C:211–26.
17. Poretti A, Wolf NI, Boltshauser E. Differential diagnosis of cerebellar atrophy in childhood. Eur J Paediatr Neurol. 2008;12:155–67.
18. Poretti A, Boltshauser E. Cerebellar dysplasia. In: Boltshauser E, Schmahmann JD, editors. Cerebellar disorders in children. London: Mac Keith Press; 2012. p. 172–6.
19. Isikay S. Cerebellar hypoplasia in a case with neurofibromatosis type 1. BMJ Case Rep 2013;2013.
20. Ruggieri M, Upadhyaya M, Di Rocco C, Gabriele A, Pascual-Castroviejo I. Neurofibromatosis type 1 & related disorders. In: Ruggieri M, Pascual-Castroviejo I, Di Rocco C, editors. Neurocutaneous disorders. New York: Springer; 2008. p. 51–151.
21. Pascual-Castroviejo I, Pascual-Pascual SI, Burgueno M, et al. [Unilateral facial and cerebral hyperplasia associated with neurofibromatosis type 1. Report of four patients]. Rev Neurol. 2006;43:346–52.
22. Al-Hail H, Ruiz-Miyares F, Deleu D, Mesraoua B. [Cerebellar hypoplasia and vertebral indentations in a case of neurofibromatosis type I]. Rev Neurol. 2008;46:626–7.
23. Rea D, Brandsema JF, Armstrong D, et al. Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics. 2009;124:e476–83.
24. Ghosh PS, Rothner AD, Emch TM, Friedman NR, Moodley M. Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol. 2013;28:95–101.
25. Kaas B, Huisman TA, Tekes A, et al. Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1. J Child Neurol. 2013;28:561–9.
26. Sanchez-Ortiz E, Cho W, Nazarenko I, et al. NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development. Genes Dev. 2014;28:2407–20.
27. Benbir G, Kara S, Yalcinkaya BC, et al. Unilateral cerebellar hypoplasia with different clinical features. Cerebellum. 2011;10:49–60.
28. Poretti A, Prayer D, Boltshauser E. Morphological spectrum of prenatal cerebellar disruptions. Eur J Paediatr Neurol. 2009;13:397–407.
29. Poretti A, Limperopoulos C, Roulet-Perez E, et al. Outcome of severe unilateral cerebellar hypoplasia. Dev Med Child Neurol. 2010;52:718–24.
30. Massoud M, Cagneaux M, Garel C, et al. Prenatal unilateral cerebellar hypoplasia in a series of 26 cases: significance and implications for prenatal diagnosis. Ultrasound Obstet Gynecol. 2014;44:447–54.
31. Gutmann DH, Rasmussen SA, Wolkenstein P, et al. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology. 2002;59:759–61.
32. Huttner AJ, Kieran MW, Yao X, et al. Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatr Blood Cancer. 2010;54:890–6.
33. Jeong TS, Yee GT. Glioblastoma in a patient with neurofibromatosis type 1: a case report and review of the literature. Brain Tumor Res Treat. 2014;2:36–8.
34. Weingart MF, Roth JJ, Hutt-Cabezas M, et al. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget 2014.
35. Wassmer E, Davies P, Whitehouse WP, Green SH. Clinical spectrum associated with cerebellar hypoplasia. Pediatr Neurol. 2003;28:347–51.
36. North K, Hyman S, Barton B. Cognitive deficits in neurofibromatosis 1. J Child Neurol. 2002;17:605–12. discussion 27–9, 46–51.
37. Hyman SL, Arthur Shores E, North KN. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol. 2006;48:973–7.
38. Lorenzo J, Barton B, Acosta MT, North K. Mental, motor, and language development of toddlers with neurofibromatosis type 1. J Pediatr. 2011;158:660–5.